Axsome Therapeutics Inc
Research Axsome Therapeutics Inc (AXSM) on Bullrun: market cap USD 8.80B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAXSM
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 8.80B
- Financial periodQ2 2026
- RevenueUSD 218.38M
- Net income-USD 51.31M
- Free cash flow-USD 33.40M
- Gross margin93.8%
Valuation Snapshot
latest market cap is USD 8.80B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 638.50M | -USD 183.17M | -USD 93.89M | 92.6% | -3.68 | USD 322.93M | USD 187.75M | USD 88.30M |
| FY2024 | USD 385.69M | -USD 287.22M | -USD 128.68M | 91.4% | -5.99 | USD 315.35M | USD 180.71M | USD 57.02M |
| FY2023 | USD 270.60M | -USD 239.24M | -USD 145.66M | 90.4% | -5.27 | USD 386.19M | USD 178.07M | USD 190.98M |
| FY2022 | USD 50.04M | -USD 187.13M | -USD 117.21M | 89.6% | -4.6 | USD 200.84M | USD 94.26M | USD 109.56M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 8.80B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 9.29B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 4.12B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 3.77B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.35B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.43B | n/a | n/a | n/a |
About Axsome Therapeutics Inc
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Axsome Therapeutics Inc's market cap?
Axsome Therapeutics Inc's market capitalization is USD 8.80B.
What does Axsome Therapeutics Inc do?
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.